S&P 500   3,856.00 (-1.77%)
DOW   31,577.88 (-1.20%)
QQQ   316.59 (-2.33%)
AAPL   122.92 (-1.94%)
MSFT   231.74 (-1.20%)
FB   258.52 (-2.19%)
GOOGL   2,034.48 (-2.37%)
AMZN   3,095.00 (-2.04%)
TSLA   700.42 (-5.61%)
NVDA   538.95 (-7.07%)
BABA   244.52 (-2.32%)
CGC   34.04 (-4.38%)
GE   12.88 (-1.83%)
MU   90.49 (-2.19%)
NIO   47.98 (-7.48%)
AMD   83.45 (-4.01%)
T   28.77 (-2.08%)
F   11.92 (-2.85%)
ACB   11.12 (-4.47%)
DIS   193.88 (-1.84%)
BA   220.73 (-3.75%)
NFLX   542.59 (-1.96%)
BAC   36.23 (-0.41%)
S&P 500   3,856.00 (-1.77%)
DOW   31,577.88 (-1.20%)
QQQ   316.59 (-2.33%)
AAPL   122.92 (-1.94%)
MSFT   231.74 (-1.20%)
FB   258.52 (-2.19%)
GOOGL   2,034.48 (-2.37%)
AMZN   3,095.00 (-2.04%)
TSLA   700.42 (-5.61%)
NVDA   538.95 (-7.07%)
BABA   244.52 (-2.32%)
CGC   34.04 (-4.38%)
GE   12.88 (-1.83%)
MU   90.49 (-2.19%)
NIO   47.98 (-7.48%)
AMD   83.45 (-4.01%)
T   28.77 (-2.08%)
F   11.92 (-2.85%)
ACB   11.12 (-4.47%)
DIS   193.88 (-1.84%)
BA   220.73 (-3.75%)
NFLX   542.59 (-1.96%)
BAC   36.23 (-0.41%)
S&P 500   3,856.00 (-1.77%)
DOW   31,577.88 (-1.20%)
QQQ   316.59 (-2.33%)
AAPL   122.92 (-1.94%)
MSFT   231.74 (-1.20%)
FB   258.52 (-2.19%)
GOOGL   2,034.48 (-2.37%)
AMZN   3,095.00 (-2.04%)
TSLA   700.42 (-5.61%)
NVDA   538.95 (-7.07%)
BABA   244.52 (-2.32%)
CGC   34.04 (-4.38%)
GE   12.88 (-1.83%)
MU   90.49 (-2.19%)
NIO   47.98 (-7.48%)
AMD   83.45 (-4.01%)
T   28.77 (-2.08%)
F   11.92 (-2.85%)
ACB   11.12 (-4.47%)
DIS   193.88 (-1.84%)
BA   220.73 (-3.75%)
NFLX   542.59 (-1.96%)
BAC   36.23 (-0.41%)
S&P 500   3,856.00 (-1.77%)
DOW   31,577.88 (-1.20%)
QQQ   316.59 (-2.33%)
AAPL   122.92 (-1.94%)
MSFT   231.74 (-1.20%)
FB   258.52 (-2.19%)
GOOGL   2,034.48 (-2.37%)
AMZN   3,095.00 (-2.04%)
TSLA   700.42 (-5.61%)
NVDA   538.95 (-7.07%)
BABA   244.52 (-2.32%)
CGC   34.04 (-4.38%)
GE   12.88 (-1.83%)
MU   90.49 (-2.19%)
NIO   47.98 (-7.48%)
AMD   83.45 (-4.01%)
T   28.77 (-2.08%)
F   11.92 (-2.85%)
ACB   11.12 (-4.47%)
DIS   193.88 (-1.84%)
BA   220.73 (-3.75%)
NFLX   542.59 (-1.96%)
BAC   36.23 (-0.41%)
Log in
NASDAQ:BPTH

Bio-Path Price Target, Predictions & Analyst Ratings

$6.70
-0.16 (-2.33 %)
(As of 02/25/2021 02:29 PM ET)
Add
Compare
Today's Range
$6.46
Now: $6.70
$6.88
50-Day Range
$3.93
MA: $5.40
$11.77
52-Week Range
$2.92
Now: $6.70
$24.34
Volume5,603 shs
Average Volume3.33 million shs
Market Capitalization$46.55 million
P/E RatioN/A
Dividend YieldN/A
Beta2.02

Analyst Ratings

Bio-Path (NASDAQ:BPTH) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for Bio-Path in the last 12 months. Their average twelve-month price target is $10.00, predicting that the stock has a possible upside of 49.25%. The high price target for BPTH is $10.00 and the low price target for BPTH is $10.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
BPTH Consensus Rating: BuyBuyBuyBuy
BPTH Consensus Rating Score: 3.003.003.003.00
BPTH Analyst Ratings: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
BPTH Consensus Price Target: $10.00$10.00$10.00$12.00
BPTH Price Target Upside: 49.25% upside198.51% upside198.51% upside142.42% upside

Bio-Path (NASDAQ:BPTH) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Bio-Path (NASDAQ:BPTH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/16/2020HC WainwrightLower Price TargetBuy$12.00 ➝ $10.00Medium
(Data available from 2/25/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.